OCI N.V. announced that its Non-Executive Board of Directors will propose the appointment of Mr. Gregory Heckman as an independent non-executive member of the Board of Directors to the next general meeting of shareholders to be held on 10 June 2015. Mr. Heckman is a US citizen with more than 30 years of experience in the agriculture and energy industries. From 2008 until 2014, he was president and chief executive officer of The Gavilon Group, LLC.

Further, at the AGM on 10 June 2015, Mr. Kees van der Graaf will not continue his term as an independent non-executive member of the Board of Directors of the company in order to dedicate more time to his bio-tech start-up Facio Therapies BV. Mr. Van der Graaf has served the company's Board of Directors since 2013, chaired the Health, Safety and Environment Committee and has also been a member of the Nomination & Governance Committee during that time.